Search research articles
Contact Us
Filters
Showing results (411-420 of 643) with videos related to
Page
of 65
Sort By:
Journal of Abnormal Psychology
|
June 1, 1980
Primary affective disorder: thought disorder in depression
E F Donnelly, I N Waldman, D L Murphy, et al.
Archives of General Psychiatry
|
February 1, 1988
Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment
J Zohar, T R Insel, R C Zohar-Kadouch, et al.
Archives of General Psychiatry
|
March 1, 1987
Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder
M F Flament, J L Rapoport, D L Murphy, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1985
Tricyclic response in obsessive compulsive disorder
T R Insel, E A Mueller, J C Gillin, et al.
Psychiatry Research
|
May 1, 1983
Effect of long-term clorgyline administration on human platelet alpha-adrenergic receptor binding and platelet cyclic AMP responses
L J Siever, M S Kafka, T R Insel, et al.
Psychopharmacology
|
January 1, 1995
Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors
P Mazzola-Pomietto, C S Aulakh, K M Wozniak, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1986
Anti-beta-endorphin immunoglobulin G in humans
B F Roy, J W Rose, H F McFarland, et al.
Archives of General Psychiatry
|
January 1, 1989
Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action
C Benkelfat, D L Murphy, J Zohar, et al.
Science (New York, N.Y.)
|
September 26, 1980
Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisol
S C Risch, R M Cohen, D S Janowsky, et al.
Psychopharmacology
|
January 1, 1982
REM sleep suppression induced by selective monoamine oxidase inhibitors
R M Cohen, D Pickar, D Garnett, et al.
Page
of 65
Search research articles
Search
Showing results (411-420 of 643) with videos related to
Sort By:
Page
of 65
Journal of Abnormal Psychology
|
June 1, 1980
Primary affective disorder: thought disorder in depression
E F Donnelly, I N Waldman, D L Murphy, et al.
Archives of General Psychiatry
|
February 1, 1988
Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment
J Zohar, T R Insel, R C Zohar-Kadouch, et al.
Archives of General Psychiatry
|
March 1, 1987
Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder
M F Flament, J L Rapoport, D L Murphy, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1985
Tricyclic response in obsessive compulsive disorder
T R Insel, E A Mueller, J C Gillin, et al.
Psychiatry Research
|
May 1, 1983
Effect of long-term clorgyline administration on human platelet alpha-adrenergic receptor binding and platelet cyclic AMP responses
L J Siever, M S Kafka, T R Insel, et al.
Psychopharmacology
|
January 1, 1995
Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors
P Mazzola-Pomietto, C S Aulakh, K M Wozniak, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1986
Anti-beta-endorphin immunoglobulin G in humans
B F Roy, J W Rose, H F McFarland, et al.
Archives of General Psychiatry
|
January 1, 1989
Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action
C Benkelfat, D L Murphy, J Zohar, et al.
Science (New York, N.Y.)
|
September 26, 1980
Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisol
S C Risch, R M Cohen, D S Janowsky, et al.
Psychopharmacology
|
January 1, 1982
REM sleep suppression induced by selective monoamine oxidase inhibitors
R M Cohen, D Pickar, D Garnett, et al.
Page
of 65